Vivos Therapeutics, Inc. - 8-K Filing
Vivos Therapeutics raised $2.1 million through a private placement offering on June 30, 2026, selling 3,608,496 units at $0.582 per unit to V-Co Investors 4 LLC and Bigger Capital Fund. Each unit included one share of Series A Convertible Preferred Stock ($0.456 stated value), a warrant exercisable for common stock at $0.456/share, and two subscription rights contingent on SEC registration effectiveness. R. Kirk Huntsman indirectly participated with approximately $50,000 via V-Co 4. (Items: 1.01 Entry into a Material Definitive Agreement, 5.03 below, 3.02 Unregistered Sales of Equity Securities, 9.01 Financial Statements and Exhibits)
Tickers: $VVOS